Adiposity signals and food reward: Expanding the CNS roles of insulin and leptin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Figlewicz, Dianne P ^a,b,c  

^a Seattle Office   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Central nervous system; Dopamine; Food intake

Indexed keywords

DOPAMINE; INSULIN; LEPTIN; NEUROHORMONE;

BRAIN STEM; CALORIE; CENTRAL NERVOUS SYSTEM; EATING DISORDER; ENERGY BALANCE; FOOD INTAKE; HORMONAL REGULATION; HYPOTHALAMUS; MENTAL DISEASE; NEGATIVE FEEDBACK; OBESITY; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SUBSTANCE ABUSE;

EID: 0037385790     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00602.2002     Document Type: Review

References (133)

1. Ahima RS and Osei SY. Molecular regulation of eating behavior: new insights and prospects for therapeutic strategies. Trends Mol Med 7: 205-213, 2001.
2. Air EL, Benoit SC, Clegg DJ, Seeley RJ, and Woods SC. Insulin and leptin combine additively to reduce food intake and body weight in rats. Endocrinology 143: 2449-2452, 2002.
3. Air EL, Benoit SC, Smith KAB, Clegg DJ, and Woods SC. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 72: 423-429, 2002.
4. Air EL, Strowski MZ, Benoit SC, Conarello SL, Salituro GM, Guan XM, Liu K, Woods SC, and Zhang BB. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat Med 8: 179-183, 2002.
5. Arase K, Fisler JS, Shargill NS, York DA, and Bray GA. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. Am J Physiol Regul Integr Comp Physiol 255: R974-R981, 1988.
6. Banks W, Clever C, and Farrell C. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol Endocrinol Metab 278: E1158-E1165, 2000.
7. Banks W, DiPalma C, and Farrell C. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20: 1341-1345, 1999.
8. Banks W, King B, Rossiter K, Olson R, Olson G, and Kastin A. Obesity-inducing lesions of the central nervous system alter leptin uptake by the blood-brain barrier. Life Sci 69: 2765-2773, 2001.
9. Banks W, Niehoff M, Martin D, and Farrell C. Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res 950: 130-136, 2002.
10. Barsh GS and Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev 3: 589-600, 2002.
11. Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D Jr, and Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 848: 114-123, 1999.
12. Beck B. Neuropeptides and obesity. Nutrition 16: 916-923, 2000.
13. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20: 1-25, 1996.
14. Berridge KC and Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28: 309-369, 1998.
15. Brief DJ and Davis JD. Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res Bull 12: 571-575, 1984.
16. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, and Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125, 2000.
17. Carelli RM. Nucleus accumbens cell firing during goal-directed behaviors for cocaine vs. 'natural' reinforcement. Physiol Behav 76: 379-387, 2002.
18. Caro J, Kolaczynski J, Nyce M, Ohannesian J, Opentanova I, Goldman W, Lynn R, Zhang P, Sinha M, and Considine R. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159-161, 1996.
19. Carr KD. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol Behav 76: 353-364, 2002.
20. Carr KD. Feeding, drug abuse, and the sensitization of reward by metabolic need. Neurochem Res 21: 1455-1467, 1996.
21. Carr KD, Kim GY, and Cabeza de Vaca S. Hypoinsulinemia may mediate the lowering of self-stimulation thresholds by food restriction and streptozotocin-induced diabetes. Brain Res 863: 160-168, 2000.
22. Carroll ME and Meisch RA. Increased drug-reinforced behavior due to food deprivation. Adv Behav Pharmacol 4: 47-88, 1984.
23. Carvalheira JBC, Ribeiro EB, Guimaraes RB, Telles MM, Velloso LA, Gontijo JAR, and Saad MJA. Characterization of selective resistance to insulin signalling in the hypothalamus of obese Zucker (fa/fa) rats (Abstract). Diabetes 51 Suppl 2: 41, 2002.
24. Carvalheira JBC, Siloto RMP, Ignacchitti I, Brenelli SL, Carvalho CRO, Leite A, Velloso LA, Gontijo JAR, and Saad MJA. Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett 500: 119-124, 2001.
25. Chavez M, Kaiyala K, Madden LJ, Schwartz MW, and Woods SC. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 109: 528-531, 1995.
26. Chavez M, Riedy CA, Van Dijk GV, and Woods SC. Central insulin and macronutrient intake in the rat. Am J Physiol Regul Integr Comp Physiol 271: R727-R731, 1996.
27. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, and Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994-996, 1996.
28. Clark JT, Kalra PS, Crowley WR, and Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427-428, 1984.
29. Clark JT, Kalra PS, and Kalra SP. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117: 2435-2442, 1985.
30. Coker GT, Studelska D, Harmon S, Burke W, and O'Malley KL. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol Brain Res 8: 93-98, 1990.
31. Coleman DL and Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217: 1298-1304, 1969.
32. 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett 70: 17-22, 1986.
33. Davis JD and Smith GP. Analysis of the rhythmic tongue movements of rats ingesting maltose and sucrose solutions. Behav Neurosci 106: 217-228, 1992.
34. Dernovsek K, Bar R, Ginsberg B, and Lioubin M. Processing of cell-bound insulin by capillary and macrovascular endothelial cells in culture. J Clin Endocrinol Metab 58: 761-763, 1984.
35. Dernovsek KD and Bar BS. Rapid transport of biologically intact insulin through cultured endothelial cells. Am J Physiol Endocrinol Metab 248: E244-E251, 1985.
36. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, and Zahm DS. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269: 8445-8454, 1994.
37. Elmquist J, Bjorbaek C, Ahima R, Flier J, and Saper C. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395: 535-547, 1998.
38. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, and Saper CB. Distribution of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395: 535-547, 1998.
39. Emond M, Schwartz GJ, Ladenheim EE, and Moran TH. Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol Regul Integr Comp Physiol 276: R1545-R1549, 1999.
40. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, and Robbins TW. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 877: 412-438, 1999.
41. Figlewicz D, Schwartz M, Seeley R, Chavez M, Baskin D, Woods S, and Porte D Jr. Endocrine regulation of food intake and body weight. J Lab Clin Med 127: 328-332, 1996.
42. Figlewicz D, Szot P, and Greenwood MRC. Insulin stimulates inositol incorporation in hippocampus of lean but not obese Zucker rats. Physiol Behav 47: 325-330, 1990.
43. Figlewicz DP, Dorsa DM, Stein LJ, Baskin DG, Paquette T, Greenwood MRC, Woods SC, and Porte D Jr. Brain and liver insulin binding is decreased in Zucker rats carrying the "fa" gene. Endocrinology 117: 1537-1543, 1985.
44. Figlewicz DP, Evans SB, Murphy J, Hoen M, and Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. In press.
45. Figlewicz DP, Higgins MS, Ng-Evans SB, and Havel PJ. Leptin reverses sucrose-conditioned place preference in food-restricted rats. Physiol Behav 73: 229-234, 2001.
46. Figlewicz DP, Ikeda H, Stein LJ, Dorsa DM, Woods SC, and Porte D Jr. Brain insulin binding is decreased in Wistar Kyoto rats carrying the "fa" gene. Peptides 7: 61-65, 1986.
47. Figlewicz DP, Sipols AJ, Seeley RJ, Chavez M, Woods SC, and Porte D Jr. Intraventricular insulin enhances the meal- suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. Behav Neurosci 109: 1-3, 1995.
48. Figlewicz DP, Szot P, Chavez M, Woods SC, and Veith RC. Intraventricular insulin increases dopaminergic transporter mRNA in rat VTA/substantia nigra. Brain Res 644: 331-334, 1994.
49. Figlewicz DP, West D, Stein LJ, Woods SC, and Porte D Jr. Insulin alters the sensitivity of baboons to CCK-induced single meal suppression. Am J Physiol Regul Integr Comp Physiol 250: R856-R860, 1986.
50. Figlewicz DP and Woods SC. Adiposity signals and brain reward mechanisms. Trends Pharmacol Sci 21: 235-236, 2000.
51. Fulton S, Woodside B, and Shizgal P. Modulation of brain reward circuitry by leptin. Science 287: 125-128, 2000.
52. Giddings SJ, Chirgwin J, and Permutt M. Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues. Diabetologia 27: 343-347, 1985.
53. Glass MJ, Billington CJ, and Levine AS. Opioids and food intake: distributed functional neural pathways? Neuropeptides 33: 360-368, 1999.
54. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, and Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143: 239-246, 2002.
55. Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts C Jr, LeRoith D, Yarden Y, and Zick Y. Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem 267: 17483-17486, 1992.
56. Hagan MM, Rushing PA, Benoit SC, Woods SC, and Seeley RJ. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am J Physiol Regul Integr Comp Physiol 280: R814-R821, 2001.
57. Havrankova J and Roth J. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829, 1978.
58. Havrankova J, Roth J, and Brownstein M. Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels: studies of obese and streptozotocin-treated rodents. J Clin Invest 64: 636-642, 1979.
59. Heidenreich KA. Insulin and IGF-I receptor signaling in cultured neurons. Ann NY Acad Sci 692: 72-88, 1993.
60. Heidenreich KA. Insulin and insulin-like growth factor I induce c-fos expression in postmitotic neurons by a protein kinase C-dependent pathway. J Biol Chem 268: 14663-14670, 1993.
61. Heidenreich KA. Insulin receptors mediate growth effects in cultured fetal neurons. II. Activation of a protein kinase that phosphorylates ribosomal protein S6. Endocrinology 125: 1458- 1463, 1989.
62. Heidenreich KA and Brandenburg D. Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain. Endocrinology 118: 1835-1842, 1986.
63. Heidenreich KA and Toledo SP. Insulin receptors mediate growth effects in cultured fetal neurons. I. Rapid stimulation of protein synthesis. Endocrinology 125: 1451-1457, 1989.
64. Hileman S, Pierroz D, Masuzaki H, Bjorbaek C, El-Haschimi K, Banks W,and Flier J. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143: 775-783, 2002.
65. Hoebel B, Hernandez L, Schwartz DH, Mark GP, and Hunter GA. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann NY Acad Sci 575: 171-191, 1989.
66. Horn CC, Addis A, and Friedman MI. Neural substrate for an integrated metabolic control of feeding behavior. Am J Physiol Regul Integr Comp Physiol 276: R113-R119, 1999.
67. Ikeda H, West DB, Pustek JJ, Figlewicz DP, Greenwood MRC, Porte D Jr, and Woods SC. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 7: 381-386, 1986.
68. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends Neurosci 22: 62-67, 1999.
69. Israel PA, Park CR, Schwartz MW, Green PK, Sipols AJ, Woods SC, Porte D Jr, and Figlewicz DP. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain Res Bull 30: 571-575, 1993.
70. Jaber M, Jones S, Giros B, and Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 12: 629-633, 1997.
71. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, and Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49: 1525-1533, 2000.
72. Kastin A and Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul Pept 92: 37-43, 2000.
73. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, and Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76: 365-377, 2002.
74. Kelley AE and Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22: 3306-3311, 2002.
75. Kenner KA and Heidenreich KA. Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons. Endocrinology 129: 301-311, 1991.
76. Kenner KA, Kusari J, and Heidenreich KA. cDNA sequence analysis of the human brain insulin receptor. Biochem Biophys Res Commun 217: 304-312, 1995.
77. King GL and Johnson S. Receptor-mediated transport of insulin across endothelial cells. Science 227: 1583-1586, 1985.
78. Kiyatkin EA. Functional significance of mesolimbic dopamine. Neurosci Biobehav Rev 19: 573-598, 1995.
79. Lepore M, Vorel SR, Lowinson J, and Gardner EL. Conditioned place preference induced by delta9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56: 2073-2080, 1995.
80. Lin L, Martin R, Schaffhauser AO, and York DA. Acute changes in the response to peripheral leptin with alteration in the diet composition. Am J Physiol Regul Integr Comp Physiol 280: R504-RS09, 2001.
81. Maness L, Banks W, and Kastin A. Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res 873: 165-167, 2000.
82. Maresh G, Maness L, Zadina J, and Kastin A. In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci 69: 67-73, 2001.
83. Mayer J and Thomas DW. Regulation of food intake and obesity. Science 156: 328-337, 1967.
84. McGowan MK, Andrews KM, Kelly J, and Grossman SP. Effects of chronic intrahypothalamic infusion of insulin on food intake and diurnal meal patterning in the rat. Behav Neurosci 104: 373-385, 1990.
85. McMinn JE, Sindelar DK, Havel PJ, and Schwartz MW. Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 141: 4442-4448, 2000.
86. Mokdad A, Bowman B, Ford E, Vinicor F, Marks J, and Koplan J. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200, 2001.
87. Mokdad A, Serdula M, Dietz W, Bowman B, Marks J, and Koplan J. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282: 1519-1522, 1999.
88. Mondal MS, Nakazato M, and Matsukura S. Orexins (hypocretins): novel hypothalamic peptides with divergent functions. Biochem Cell Biol 78: 299-305, 2000.
89. Morton GJ and Schwartz MW. The NPY/AgRP neuron and energy homeostasis. Int J Obes Relat Metab Disord 25, Suppl 5: S56-S62, 2001.
90. Nicolaidis S and Rowland N. Metering of intravenous versus oral nutrients and regulation of energy balance. Am J Physiol 231:661-668, 1976.
91. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG Jr, and Schwartz MW. Key enzyme in leptin-induced anorexia. Nature 413: 794-795, 2001.
92. Papp M. Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats. Pharmacol Biochem Behav 52: 889-893, 1988.
93. Patterson T, Brot MD, Zavosh A, Schenk JO, Szot P, and Figlewicz DP. Fasting decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68: 11-20, 1998.
94. Porte D Jr and Woods SC. Regulation of food intake and body weight by insulin. Diabetalogia 20, Suppl: 274-280, 1981.
95. Richard D, Huang Q, and Timofeeva E. The corticotropin-releasing hormone system in the regulation of energy balance in obesity. Int J Obes Relat Metab Disord 24, Suppl 2: S36-S39, 2000.
96. Richardson NR and Gratton A. Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study. J Neurosci 16: 8160- 8169, 1996.
97. Robbins TW and Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6: 228-236, 1996.
98. Rollins BL and King BM. Amygdala-lesion obesity: what is the role of the various amygdaloid nuclei? Am J Physiol Regul Integr Comp Physiol 279: R1348-R1356, 2000.
99. Rulifson E, Kim S, and Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296:1118-1120, 2002.
100. Schneider LH, Davis JD, Watson CA, and Smith GP. Similar effect of raclopride and reduced sucrose concentration on the microstructure of sucrose sham feeding. Eur J Pharmacol 186: 61-70, 1990.
101. Schultz W. Getting formal with dopamine and reward. Neuron 36:241-263, 2002.
102. Schwartz M, Figlewicz D, Kahn S, Baskin D, Greenwood M, and Porte D Jr. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides 11: 467-472, 1990.
103. Schwartz M, Peskind E, Raskind M, Boyko E, and Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2: 589-593, 1996.
104. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, and Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13: 387-414, 1992.
105. Schwartz MW, Figlewicz DP, Woods SC, Porte D Jr, and Baskin DG. Insulin, neuropeptide Y, and food intake. Ann NY Acad Sci 692: 60-71, 1993.
106. Schwartz MW, Sipols AJ, Kahn SE, Lattemann DF, Taborsky G Jr, Bergman RN, Woods SC, and Porte D Jr. Kinetics and specificity of insulin uptake from plasma to cerebrospinal fluid. Am J Physiol Endocrinol Metab 259: E378-E383, 1990.
107. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP, and Porte D Jr. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130: 3608-3616, 1992.
108. Shalev U, Grimm JW, and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42, 2002.
109. Shalev U, Yap J, and Shaham Y. Leptin attenuates food deprivation-induced relapse to heroin seeking. J Neurosci 21: RC129, 2001.
110. Shemer J, Adamo M, Raizada MK, Heffez D, Zick Y, and LeRoith D. Insulin and IGF-I stimulate phosphorylation of their respective receptors in intact neuronal and glial cells in primary culture. J Mol Neurosci 1: 3-8, 1989.
111. Shizgal P, Fulton S, and Woodside B. Brain reward circuitry and the regulation of energy balance. Int J Obesity 25, Suppl 5: S17-S21, 2001.
112. Singh BS, Rajakumar PA, Eves EM, Rosner MR, Wainer BH, and Devaskar SU. Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regul Pept 69: 7-14, 1997.
113. Sipols AJ, Baskin DG, and Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44: 147-151, 1995.
114. Sipols AJ, Bayer J, Bennett R, and Figlewicz DP. Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats. Peptides. In press.
115. Sipols AJ, Stuber GD, Klein SN, Higgins MS, and Figlewicz DP. Insulin and raclopride combine to decrease short-term intake of sucrose solutions. Peptides 21: 1361-1367, 2000.
116. Smith GP. Dopamine and food reward. Prog Psychobiol Physiol Psychol 16: 83-143, 1995.
117. Smith GP and Gibbs J. Postprandial satiety. Prog Psychobiol Physiol Psychol 8: 179-242, 1979.
118. Spanagel R and Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 22: 521-527, 1999.
119. Stein LJ, Dorsa DM, Baskin DG, Figlewicz DP, Porte D Jr, and Woods SC. Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations of obese Zucker rats. Endocrinology 121: 1611-1615, 1987.
120. Stratford TR and Kelley AE. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19: 11040-11048, 1999.
121. Swerdlow NR, Van der Kooy D, Koob GF, and Wenger JR. Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety. Life Sci 32: 2087-2093, 1983.
122. Unger J, Livingston JN, and Moss AM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36: 343-362, 1991.
123. Vaughan RA, Huff RA, Uhl GR, and Kuhar MJ. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 272: 15541-15546, 1997.
124. Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, and Mendelsohn FAO. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121: 1562-1570, 1987.
125. White JD, Olchovsky D, Kershaw M, and Berelowitz M. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126: 765-772, 1990.
126. Wilson C, Nomikos GG, Collu M, and Fibiger HC. Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci 15: 5169-5178, 1995.
127. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron 36: 229-240, 2002.
128. Wise RA and Hoffman DC. Localization of drug reward mechanisms by intracranial injections. Synapse 10: 247-263, 1992.
129. Wise RA and Rompre PP. Brain dopamine and reward. Annu Rev Psychol 40: 191-225, 1989.
130. Woods SC, Lotter EC, McKay LD, and Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282: 503-505, 1979.
131. Zahniser NR, Goens MB, Hanaway PJ, and Vinych JV. Characterization and regulation of insulin receptors in rat brain. J Neurochem 42: 1354-1362, 1984.
132. Zhang M, Gosnell BA, and Kelley AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 284: 908-914, 1998.
133. Zhang Y, Proenca R, Maffie M, Barone M, Leopold L, and Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.